BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32111493)

  • 21. [Multiple myeloma cell line U266 apoptosis induced by velcade].
    Chen LJ; Li JY; Qian SX; Zhu GR; Zheng WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):696-9. PubMed ID: 16928302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
    Holien T; Olsen OE; Misund K; Hella H; Waage A; Rø TB; Sundan A
    Eur J Haematol; 2013 Oct; 91(4):339-46. PubMed ID: 23869695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
    Morelli MB; Offidani M; Alesiani F; Discepoli G; Liberati S; Olivieri A; Santoni M; Santoni G; Leoni P; Nabissi M
    Int J Cancer; 2014 Jun; 134(11):2534-46. PubMed ID: 24293211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib.
    Chen G; Hu K; Sun H; Zhou J; Song D; Xu Z; Gao L; Lu Y; Cheng Y; Feng Q; Zhang H; Wang Y; Hu L; Lu K; Wu X; Li B; Zhu W; Shi J
    Cancer Lett; 2020 May; 478():45-55. PubMed ID: 32160976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro.
    Ghoneum M; Gollapudi S
    Neoplasma; 2011; 58(2):118-23. PubMed ID: 21275460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib.
    Francisco V; Ruiz-Fernández C; González-Rodríguez M; Cordero-Barreal A; Pino J; Viñuela JE; Lago F; Conde J; Gómez R; Carvalho GR; Costa Pereira TM; Campos-Toimil M; Gualillo O
    J Ethnopharmacol; 2021 May; 272():113932. PubMed ID: 33609728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.
    Zhang Z; Wang W; Ma D; Xiong J; Kuang X; Zhang S; Fang Q; Wang J
    Aging (Albany NY); 2020 Apr; 12(8):6611-6629. PubMed ID: 32298237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.
    Elmahi AY; Niu C; Li W; Li D; Wang GJ; Hao SS; Cui JW
    Asian Pac J Cancer Prev; 2013; 14(11):6469-73. PubMed ID: 24377552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomib.
    Walsby EJ; Pratt G; Hewamana S; Crooks PA; Burnett AK; Fegan C; Pepper C
    Mol Cancer Ther; 2010 Jun; 9(6):1574-82. PubMed ID: 20515939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
    Beider K; Rosenberg E; Dimenshtein-Voevoda V; Sirovsky Y; Vladimirsky J; Magen H; Ostrovsky O; Shimoni A; Bromberg Z; Weiss L; Peled A; Nagler A
    J Hematol Oncol; 2020 Nov; 13(1):158. PubMed ID: 33239060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway.
    Yang L; Chen J; Han X; Zhang E; Huang X; Guo X; Chen Q; Wu W; Zheng G; He D; Zhao Y; Yang Y; He J; Cai Z
    Protein Cell; 2018 Sep; 9(9):770-784. PubMed ID: 29441489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AK-968 efficiently inhibits proliferation and induces cell apoptosis in human multiple myeloma cells.
    Dai Y; Xu Y; Jiang Y; Jiang W; Liu X; Zhang C
    Pharmazie; 2019 Mar; 74(3):150-153. PubMed ID: 30961680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.
    Badr G; Al-Sadoon MK; Abdel-Maksoud MA; Rabah DM; El-Toni AM
    PLoS One; 2012; 7(12):e51661. PubMed ID: 23251606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production.
    Ramos-Acosta C; Huerta-Pantoja L; Salazar-Hidalgo ME; Mayol E; Jiménez-Vega S; García-Peña P; Jordi-Cruz J; Baquero C; Porras A; Íñigo-Rodríguez B; Benavente CM; López-Pastor AR; Gómez-Delgado I; Urcelay E; Candel FJ; Anguita E
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732105
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Terzi H; Altun A; Şencan M
    Indian J Med Res; 2019 Dec; 150(6):630-634. PubMed ID: 32048627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
    Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.
    Zhang H; Pang Y; Ma C; Li J; Wang H; Shao Z
    Oncol Res; 2018 Apr; 26(3):421-429. PubMed ID: 28899456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.